{"id":"https://openalex.org/W1576822277","doi":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","title":"Clinical and immunomodulatory effects of bevacizumab and low\u2010dose interleukin\u20102 in patients with metastatic renal cell carcinoma: results from a phase II trial","display_name":"Clinical and immunomodulatory effects of bevacizumab and low\u2010dose interleukin\u20102 in patients with metastatic renal cell carcinoma: results from a phase II trial","publication_year":2010,"publication_date":"2010-09-14","ids":{"openalex":"https://openalex.org/W1576822277","doi":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","mag":"1576822277","pmid":"https://pubmed.ncbi.nlm.nih.gov/20840548"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-410x.2010.09573.x","doi":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103556255","display_name":"Jorge Alberto Garcia","orcid":"https://orcid.org/0009-0001-6897-4237","observed_orcids":["https://orcid.org/0009-0001-6897-4237"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jorge A. Garcia","raw_affiliation_strings":["Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH, USA. Garciaj4@ccf.org","Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH, USA. Garciaj4@ccf.org","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111567764","display_name":"Tarek M. Mekhail","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tarek Mekhail","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111957341","display_name":"Paul J. Elson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Elson","raw_affiliation_strings":["Department of Biostatistics, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087285442","display_name":"Pierre L. Triozzi","orcid":"https://orcid.org/0000-0003-2488-6136","observed_orcids":["https://orcid.org/0000-0003-2488-6136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Triozzi","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082200198","display_name":"Cheryl Nemec","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl Nemec","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103138544","display_name":"Robert Dreicer","orcid":"https://orcid.org/0000-0002-0552-6912","observed_orcids":["https://orcid.org/0000-0002-0552-6912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Dreicer","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald M. Bukowski","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025529463","display_name":"Brian I. Rini","orcid":"https://orcid.org/0000-0002-2212-080X","observed_orcids":["https://orcid.org/0000-0002-2212-080X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian I Rini","raw_affiliation_strings":["Department of Solid Tumor Oncology, Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor Oncology, Department of Urology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103556255"],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":{"value":4770,"currency":"USD","value_usd":4770},"apc_paid":null,"fwci":1.9648,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.85759463,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"107","issue":"4","first_page":"562","last_page":"570"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9769999980926514},{"id":"https://openalex.org/keywords/low-dose-il-2","display_name":"low-dose interleukin-2","score":0.9570000171661377},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.7990000247955322},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.9739999771118164},{"id":"https://openalex.org/keywords/plasmacytoid-dendritic-cells","display_name":"plasmacytoid dendritic cells","score":0.8799999952316284},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6209999918937683},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.5419999957084656},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4269999861717224},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8080000281333923},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6269999742507935},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6629999876022339},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6420000195503235},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9117326736450195},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9033302068710327},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6818151473999023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5604965090751648},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.541192889213562},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5038303732872009},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.49777868390083313},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.49764326214790344},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3873010277748108},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3547314405441284},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2901434302330017},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.17976850271224976}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004812","descriptor_name":"Epidemiologic Methods","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004812","descriptor_name":"Epidemiologic Methods","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004812","descriptor_name":"Epidemiologic Methods","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1464-410x.2010.09573.x","doi":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-410x.2010.09573.x","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},{"id":"pmid:20840548","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20840548","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU international","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8500000238418579}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1497429764","https://openalex.org/W1603680605","https://openalex.org/W1666874820","https://openalex.org/W1928193662","https://openalex.org/W1968848897","https://openalex.org/W1968950760","https://openalex.org/W1980241157","https://openalex.org/W1985126564","https://openalex.org/W1987446429","https://openalex.org/W1999966467","https://openalex.org/W2030578708","https://openalex.org/W2031063133","https://openalex.org/W2046507292","https://openalex.org/W2050662171","https://openalex.org/W2057427371","https://openalex.org/W2061358741","https://openalex.org/W2063444606","https://openalex.org/W2065200279","https://openalex.org/W2070779832","https://openalex.org/W2070826648","https://openalex.org/W2076424556","https://openalex.org/W2088571368","https://openalex.org/W2098136315","https://openalex.org/W2100669312","https://openalex.org/W2101456601","https://openalex.org/W2104540972","https://openalex.org/W2118325137","https://openalex.org/W2119088518","https://openalex.org/W2131055846","https://openalex.org/W2137379725","https://openalex.org/W2139248078","https://openalex.org/W2139276825","https://openalex.org/W2143782771","https://openalex.org/W2145151859","https://openalex.org/W2149456801","https://openalex.org/W2150594590","https://openalex.org/W2155012968","https://openalex.org/W2165330900","https://openalex.org/W2170181841","https://openalex.org/W2171469612","https://openalex.org/W2268972797","https://openalex.org/W2334694951","https://openalex.org/W4285719527","https://openalex.org/W4298379398","https://openalex.org/W4313333674"],"related_works":["https://openalex.org/W3142026086","https://openalex.org/W2028827184","https://openalex.org/W2146312028","https://openalex.org/W3146277049","https://openalex.org/W4200337742","https://openalex.org/W811056451","https://openalex.org/W4226271282","https://openalex.org/W2995532498","https://openalex.org/W2528167051","https://openalex.org/W2188607138"],"abstract_inverted_index":{"Study":[0],"Type":[1],"\u2013":[2],"Therapy":[3],"(case":[4],"series)":[5],"Level":[6],"of":[7,40,49,60,92,117,126,134,228,234,251,308,315,320],"Evidence":[8],"4":[9],"What\u2019s":[10],"known":[11],"on":[12,327],"the":[13,18,38,41,47,55,113,121],"subject?":[14],"and":[15,26,45,89,110,123,156,191,197,224,243,249,259,271,318],"What":[16],"does":[17],"study":[19,36],"add?":[20],"As":[21],"single":[22],"agents,":[23],"both":[24],"IL\u20102":[25,138,157,294,304],"bevacizumab":[27,61,135,149],"have":[28],"demonstrated":[29,37],"clinical":[30,122,297],"activity":[31,51,107,298],"in":[32,108,183,247,282,299],"advanced":[33],"RCC.":[34],"This":[35],"feasibility":[39],"combination,":[42,128],"its":[43],"safety":[44],"unfortunately":[46],"lack":[48],"enhanced":[50],"if":[52],"one":[53],"compares":[54],"combination":[56],"with":[57,145,202],"existing":[58],"data":[59,312],"alone.":[62],"OBJECTIVE":[63],"Low\u2010dose":[64],"interleukin\u20102":[65],"(IL\u20102)":[66],"is":[67,99],"a":[68,129,172],"historical":[69],"treatment":[70,266],"for":[71,166],"metastatic":[72],"renal":[73],"cell":[74,86],"carcinoma":[75],"(mRCC).":[76],"Increased":[77],"vascular":[78],"endothelial":[79],"growth":[80],"factor":[81],"(VEGF)":[82],"levels":[83,270,317],"inhibit":[84],"dendritic":[85],"(DC)":[87],"differentiation":[88],"augment":[90,112],"production":[91],"immunosuppressive":[93,321],"regulatory":[94],"T":[95,283],"(Treg)":[96],"cells.":[97,279],"Bevacizumab":[98,291],"an":[100,225,325],"antibody":[101],"that":[102],"binds":[103],"to":[104,164],"VEGF,":[105],"has":[106,295],"mRCC":[109,147,204],"may":[111],"anti\u2010tumour":[114],"immune":[115],"effects":[116,125,190],"IL\u20102.":[118],"To":[119],"determine":[120],"immunomodulatory":[124,189],"this":[127],"prospective,":[130],"phase":[131],"II":[132],"trial":[133],"plus":[136,292],"low\u2010dose":[137,293],"was":[139,211,222,302],"conducted.":[140],"PATIENTS":[141],"AND":[142],"METHODS":[143],"Patients":[144],"untreated":[146,203],"received":[148],"(10":[150],"mg/kg":[151],"i.v.":[152],"every":[153],"2":[154],"weeks)":[155],"(125":[158],"000":[159],"units/kg/day":[160],"subcutaneously":[161],"from":[162],"Monday":[163],"Friday":[165],"6":[167],"consecutive":[168],"weeks":[169],"followed":[170],"by":[171],"2\u2010week":[173],"rest":[174],"period).":[175],"Endpoints":[176],"included":[177],"progression\u2010free":[178,209],"survival,":[179],"Response":[180],"Evaluation":[181],"Criteria":[182],"Solid":[184],"Tumors\u2010defined":[185],"objective":[186,219],"response":[187,220],"rate,":[188],"safety.":[192],"RESULTS":[193],"Between":[194],"January":[195],"2005":[196],"September":[198],"2007,":[199],"twenty\u2010six":[200],"patients":[201,229],"were":[205,245,288],"enrolled.":[206],"The":[207,218],"median":[208],"survival":[210],"9.6":[212],"months":[213],"(95%":[214],"CI,":[215],"4.1\u201316.9":[216],"months)":[217],"rate":[221],"15%":[223],"additional":[226],"38%":[227],"had":[230],"tumour":[231],"burden":[232],"reduction":[233],"<30%.":[235],"Grade":[236],"3":[237],"constitutional":[238],"adverse":[239],"events":[240],"(fatigue,":[241],"fever/chills)":[242],"neutropenia":[244],"observed":[246],"42%":[248],"12%":[250],"patients,":[252],"respectively.":[253],"Peripheral":[254],"blood":[255],"CD1c":[256],"+":[257,261,273,275,277],"myeloid":[258],"CD303":[260],"plasmacytoid":[262],"DC":[263,328],"increased":[264],"during":[265],"as":[267],"did":[268],"IL\u20108":[269],"CD4":[272],"CD25":[274],"FoxP3":[276],"Treg":[278,322],"No":[280],"changes":[281],"helper":[284],"type":[285],"1/2\u2010associated":[286],"cytokines":[287],"observed.":[289],"CONCLUSION":[290],"modest":[296],"mRCC.":[300],"Toxicity":[301],"largely":[303],"related":[305],"without":[306,324],"enhancement":[307],"bevacizumab\u2010related":[309],"toxicity.":[310],"Biological":[311],"indicate":[313],"inhibition":[314],"VEGF":[316],"increase":[319],"cells":[323],"effect":[326],"activation.":[329]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}